Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2022. "First...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, May 16, 2022, at 4:30 p.m....
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, May 16, 2022, at 4:30 p.m....
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) insider Ron Price sold 15,072 shares of the company’s stock in a transaction on Friday, April 22nd. The shares were sold at an average price of $0.98, for a total transaction of $14,770.56. Following the completion of the sale, the insider now directly owns 40,610 shares of the […]